Correlation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu, Nepal

Antimicrobial Resistance and Infection Control

Volumn 5, Issue 1, 2016, Pages

  Neupane, Sanjeev ^a   Pant, Narayan Dutt ^b   Khatiwada, Saroj ^c   Chaudhary, Raina ^d   Banjara, Megha Raj ^a  

^a TRIBHUVAN UNIVERSITY   (Nepal)

^b GRANDE INTERNATIONAL HOSPITAL   (Nepal)

^c CIST College   (Nepal)

^d Shree Birendra Hospital   (Nepal)

Author keywords

Biofilm; Escherichia coli; Extended spectrum beta lactamase; Nepal; Urinary tract infection

Indexed keywords

AMIKACIN; AMOXICILLIN; ANTIBIOTIC AGENT; CEFALEXIN; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN;

AGAR DIFFUSION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BIOFILM; CONTROLLED STUDY; DISK DIFFUSION; ENZYME SYNTHESIS; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; HUMAN; MAJOR CLINICAL STUDY; NEPAL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; URINALYSIS; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

EID: 85006186558     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/s13756-016-0104-9     Document Type: Article

References (25)

1. Ramesh N, Sumathi CS, Balasubramanian V, Palaniappan KR, Kannan VR. Urinary tract infection and antimicrobial susceptibility pattern of extended spectrum beta lactamase producing clinical isolates. Adv Biol Res. 2008;2:78-82.
2. Dromigny JA, Nabeth P, Perrier Gros Claude JD. Distribution and susceptibility of bacterial urinary tract infection in Dakar, Senegal. Int J Antimicrob Agents. 2002;20:339-47.
3. Gupta K. Increasing antimicrobial resistance and the management of uncomplicated community acquired urinary tract infections. Int J Antimicrob. 2001;135:41-50.
4. Nicolle LE. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am. 2008;35:1-12.
5. Bhatta CP, Shrestha B, Khadka S, Swar S, Shah B, Pun K. Etiology of urinary tract infection and drug resistance cases of uropathogens. J Kath Med coll. 2012;2:114-20.
6. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA. Multidrug-resistant urinary tract isolates of E. coli: prevalence and patient demographics in the United States. J Antimicrob Chemother. 2001;45:1402-6.
7. Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis. 2000;19:112-7.
8. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum -lactamase production in Enterobacteriaceae bacteraemia: a systemic review and meta-analysis. J Antimicrob Chemother. 2007;60:913-20.
9. Soto SM. Importance of biofilms in urinary tract infections: new therapeutic approaches. Adv Biol. 2014;2014(2014):543974.
10. Rijavec M, Muller-Premru M, Zakotnik B, Bertok DZ. Virulence factors and biofilm production among Escherichia coli strains causing bacteraemia of urinary tract origin. J Med Microbio. 2008;57:1329-34.
11. Cheesbrough M. District laboratory practice in tropical countries, part II. 2nd ed. New York: Cambridge university press; 2006. p. 112-3.
12. Clinical Laboratory Standards Institute. (CLSI) CLSI document M100S-S22. Performance standards for antimicrobial susceptibility testing: Twenty second informational supplement ed. Wayne: CLSI; 2012.
13. Mathur T, Singhal S, Khan S, Upadhyay DJ, Fatma T, Rattan A. Detection of biofilm formation among the clinical isolates of staphylococci: an evaluation of three different screening methods. Indian J Med Microbiol. 2006;24:25-9.
14. Poovendran P, Vidhya N, Murugan S. Antimicrobial susceptibility pattern of ESBL and non-ESBL producing uropathogenic Escherichia coli (UPEC) and their correlation with biofilm formation. Intl J Microbiol Res. 2013;4:56-63.
15. Christensen GD, Simpson WA, Bisno AL, Beachey EH. Adherence of slime producing strains of Staphylococcus epidermidis to smooth surface. Infec Immun. 1982;37:318-26.
16. Anandkumar H, Soham G, Vinodkumar CS, Rao A, Srinivasa H. Detection of Cell Surface Hydrophobicity and Biofilm formation among ESBL and non-ESBL producing uropathogenic Escherichia coli. J Med Educ Res. 2012;2:12-20.
17. Nair BT, Bhat KG, Shantaram M. In vitro biofilm production and virulence factors of uropathogenic Escherichia coli. Int J Pharm Bio Sci. 2013;4:951-6.
18. Hanna A, Berg M, Stout V, Razatos A. Role of capsular colanic acid in adhesion of uropathogenic Escherichia coli. Appl Environ Microbiol. 2003;69:4474-81.
19. Thien-fah UK, George PA. Mechanism of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001;9:34-9.
20. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358:135-8.
21. Subramanian P, Umadevi S, Kumar S, Stephen S. Determination of correlation between biofilm and extended spectrum β lactamases producers of Enterobacteriaceae. Scho Res J. 2012;2:2-6.
22. Black JA, Moland ES, Thomson KS. AmpC disk test for detection of plasmid-mediated AmpC-b lactamases in Enterobacteriaceae lacking chromosomal AmpC-b lactamases. J Clin Microbiol. 2005;43:3110-3.
23. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657-86.
24. Gautam R, Chapagain ML, Acharya A, Rayamajhi N, Shrestha S, Ansari S, et al. Antimicrobial susceptibility patterns of Escherichia coli from various clinical sources. JCMC. 2013;3:14-7.
25. Awasthi TR, Pant ND, Dahal PR. Prevalence of Multidrug Resistant Bacteria in Causing Community Acquired Urinary Tract Infection Among the Patients Attending Outpatient Department of Seti Zonal Hospital, Dhangadi, Nepal. Nepal J Biotechnol. 2015;3(1):55-9.